| Trial ID: | L1417 |
| Source ID: | NCT01363336
|
| Associated Drug: |
Nifedipine (Adalat Cr, Baya1040)
|
| Title: |
Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hypertension
|
| Interventions: |
DRUG: Nifedipine (Adalat CR, BAYA1040)
|
| Outcome Measures: |
Primary: Evaluation of participants with Adverse Events for Safety purpose in real practice, After 6 months|General evaluation of patient concerning efficacy of AdalatCR treatment in real practice, After 6 months | Secondary: Blood pressure, Pulse rate, After 6 months|Clinical test values, in specially, microalbumin urea and serum creatinine, After 6 months|Overall evaluation, After 6 months
|
| Sponsor/Collaborators: |
Sponsor: Bayer
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
1882
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2009-11
|
| Completion Date: |
2013-07
|
| Results First Posted: |
|
| Last Update Posted: |
2015-04-06
|
| Locations: |
Many Locations, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT01363336
|
